Navigation Links
Cethromycin Achieves All Endpoints in Second Pivotal Phase III Trial for Treatment of Pneumonia
Date:11/15/2007

umococci, is a growing challenge when it comes to serious infections like CAP," said Dr. Donald Low, Head of the Division of Microbiology in the Department of Laboratory Medicine and Pathobiology at the University of Toronto in Toronto, Ontario. "Cethromycin, a new antibiotic, may be the solution to this important public health problem, as it has demonstrated a broad spectrum of antibacterial activity and an ability to overcome pneumococcal resistance in clinical trials."

Program Design

The Phase III CAP pivotal development program was comprised of two double-blind, randomized, well controlled, multi-center, multi-national, comparator trials designed to assess the safety and effectiveness of cethromycin in CAP patients compared to Biaxin. Trial CL-06 enrolled patients from clinics in Europe, South America and Israel and Trial CL-05 enrolled patients from the United States, Canada and South Africa. In both trials, cethromycin was evaluated using a 300 mg once-daily oral dosing regimen compared to 250 mg twice-daily dosing for Biaxin, both over a seven-day course of therapy. Biaxin is an FDA-approved standard of care antibiotic currently indicated for the treatment of CAP.

The primary endpoint for both trials was the clinical cure rate at the test-of-cure visit (Day 14-21 post-initiation of dosing). The eligibility of patients for each trial was based on clinical signs and symptoms as well as chest X-ray results as evaluated by an independent radiologist. Extensive electrocardiogram and liver function test monitoring were incorporated into the study design in order to examine safety in these areas and add to the safety database established in previous cethromycin clinical trials.

Results of Trial CL-05

In Trial CL-05, cethromycin met all efficacy endpoints and demonstrated a favorable safety profile as outlined below:

-- Per protocol clinical cure rate (PPc) -- cethromycin 94.0% (205/218)

compared to Biaxin 93.8% (195/208
'/>"/>

SOURCE Advanced Life Sciences Holdings, Inc.
Copyright©2007 PR Newswire.
All rights reserved

1

GOOD

Page: 1 2 3 4 5 6 7 8 9 10 11

Related medicine technology :

1. Advanced Life Sciences Collaborates with U.S. Government to Study Cethromycin as Treatment for Anthrax and Other High-Priority Biodefense Agents
2. Advanced Life Sciences to Present Data on Selected Cethromycin Therapeutic Studies at the 47th Interscience Conference on Antimicrobial Agents and Chemotherapy
3. Further Data on Safety and Efficacy of Cethromycin Presented at 47th Interscience Conference on Antimicrobial Agents and Chemotherapy
4. Further Data on Safety and Efficacy of Cethromycin Presented at 47th Interscience Conference on Antimicrobial Agents and Chemotherapy
5. Large Blinded Clinical Study Achieves High Accuracy for the Diagnosis of Melanoma Using In Vivo Confocal Microscopy
6. Avastin Achieves Impressive Rate of Curative Surgery in Patients with Advanced Colorectal Cancer
7. Phase III Clinical Trial in Newly Diagnosed Multiple Myeloma Stopped Early Due to Highly Significant Efficacy Advantage of VELCADE(R) (Bortezomib) for Injection Based Therapy Across All Endpoints
8. A Phase II, Randomized, Double Blind, Placebo-Controlled Dose-Escalating Study, Meets the Clinical Endpoints of MTR106 Tablets During the Treatment of Acute Migraine Attacks Without Aura in Females
9. Spherix Reports Second Quarter Earnings
10. Tapestry Reports Second Quarter 2007 Results
11. Callisto Reports on Second-Quarter 2007 Milestones
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/23/2013)... , May 23, 2013  Intercept Pharmaceuticals, Inc. (Nasdaq: ... company focused on the development and commercialization of novel ... as primary biliary cirrhosis, today announced that ... Officer, will present at the Deutsche Bank Securities 38th ... on Wednesday, May 29, 2013 at 4:10 p.m. ...
(Date:5/23/2013)... , May 23, 2013  Omeros Corporation (NASDAQ: ... Investigational New Drug Application (IND) to evaluate OMS824 ... U.S. Food and Drug Administration (FDA). OMS824 selectively ... areas of the brain linked to a wide ... disease and schizophrenia. OMS824 has shown promising results ...
(Date:5/23/2013)...  MedVantx, Inc., the company that has pioneered a ... the Company has completed a major expansion of its ... and the upgrade of its systems to offer a ... specialty home delivery pharmacy in Sioux Falls, ... physicians, health systems and payors novel distribution services, as ...
Breaking Medicine Technology:Investigational New Drug Application Cleared by FDA for OMS824 in Huntington's Disease 2Investigational New Drug Application Cleared by FDA for OMS824 in Huntington's Disease 3Investigational New Drug Application Cleared by FDA for OMS824 in Huntington's Disease 4MedVantx Achieves Significant Milestone of Managing $1.5B in Prescription Medications and Completes Facilities Expansion While Upgrading To Offer Current Good Manufacturer Practices (cGMP)-level Quality Systems in their Home Delivery Pharmacy 2MedVantx Achieves Significant Milestone of Managing $1.5B in Prescription Medications and Completes Facilities Expansion While Upgrading To Offer Current Good Manufacturer Practices (cGMP)-level Quality Systems in their Home Delivery Pharmacy 3
...  Today at the 21st Annual National Mobility Equipment Dealers ... Awareness Month was unveiled, which will be celebrated throughout ... of the awareness month is to teach seniors, veterans ... and mobile lifestyle through the use of wheelchair accessible ...
... 60 Plus Association today sent a letter of gratitude ... contacted the Federal Trade Commission (FTC) with concerns over ... Scripts, Inc. and Medco Health Solutions. The organization made ... of their 7.1 million supporters to defend patient choice, ...
Cached Medicine Technology:NMEDA Introduces National Mobility Awareness Month for Seniors, Veterans and People with Disabilities 260 Plus Association Applauds Opposition to PBM Merger 2
(Date:5/23/2013)... Steven Reinberg HealthDay Reporter , , THURSDAY, May ... heartburn may be at increased risk for cancers of ... smoke or drink alcohol, a new study says. ... cancers while prescription medications such as Prilosec, Nexium and ... a controversy about whether heartburn contributes to cancers of ...
(Date:5/23/2013)... of older adults with dementia are less stressed ... dementia patients receive adult day services (ADS), according ... with and care for someone with dementia can ... professor and head, human development and family studies. ... provide caregivers with a much-needed break that can ...
(Date:5/23/2013)... YORK (May 23, 2013) -- Little is known about ... why response to treatments varies between patients. Now, a ... University Medical Center and SUNY Downstate Medical Center has ... asthma, showing that it is very different from other ... Medicine , reveals that an over-active gene linked in ...
(Date:5/23/2013)... researchers at Henry Ford Hospital found "substantial evidence" that ... spinal cord could hold the key to better functional ... new hope to those who suffer stroke, the leading ... victims recover some ability to voluntarily use their hands ... weakness on one side of their bodies, while a ...
(Date:5/23/2013)... It is Go Classy Tours / Caribbean Hideaways' ... Spa , a luxury nudist resort located in the Rivera ... International Naked Painting Party. Hidden Beach is a perfect location ... Hot Tub, Nude Bars & Nightclub and Nude Dinning. ... August 15th and go through August 18th, with the actual ...
Breaking Medicine News(10 mins):Health News:Chronic Heartburn May Raise Odds for Throat Cancer: Study 2Health News:Adult day services for dementia patients provide stress relief to family caregivers 2Health News:Researchers find common childhood asthma unconnected to allergens or inflammation 2Health News:Researchers find common childhood asthma unconnected to allergens or inflammation 3Health News:Regenerating spinal cord fibers may be treatment for stroke-related disabilities 2Health News:Regenerating spinal cord fibers may be treatment for stroke-related disabilities 3Health News:Hidden Beach, the Only Luxurious All-inclusive Nudist Resort in the Mexican Caribbean, to Host Social Exposure's Naked Painting Party, Announces Go Classy Tours 2
... INDIANAPOLIS, June 22 The board of directors of Eli Lilly and ... third quarter of 2009 of $0.49 a share on outstanding common stock. ... and second quarters and maintains the annual indicated dividend rate for 2009 ... September 10, 2009, to shareholders of record at the close of business ...
... blames physician misdiagnosis as the likely cause of apparent uptick ... A newly released study in the June 2009 British Journal ... the eastern United Kingdom has concluded that the much-hyped melanoma ... The study attributed the increase in melanoma diagnoses to heightened ...
... MIAMI, June 22 Now there,s a new ... time, suggests a new,study published in the July issue of ... drinking fat free milk in the,morning helped increase satiety, or ... the next meal, as compared with a fruit drink. The,milk ...
... , , , Personalized Medicine Meeting ... The Food and Drug Administration,s (FDA,s) ability to regulate genetic ... medicine stakeholders. , , Three-quarters of the attendees ... and Drug Law Institute (FDLI) and the American Association for ...
... NIH declines to attend field hearing exploring use of Recovery ... U.S. Senator Benjamin L. Cardin (D-MD ), chaired a ... Business and Entrepreneurship in Rockville, MD, entitled " Missed ... the hearing, local and national experts in biotechnology testified about ...
... Courage Center,s two camps, Camp Courage in Maple Lake ... camp schedule for people with disabilities. , , A recent ... participants (campers and MDA staff) who tested positive for H1N1 flu ... 6-12. Courage Center officials were contacted by the MDA locally three ...
Cached Medicine News:Health News:New Study Says Purported Melanoma Epidemic is Vastly Overstated 2Health News:Drinking Milk in the Morning May Help Stave off Lunchtime Hunger 2Health News:FDA's Current Ability to Regulate Genetic Testing is Problematic, FDLI-AAAS Colloquium Attendees Say 2Health News:FDA's Current Ability to Regulate Genetic Testing is Problematic, FDLI-AAAS Colloquium Attendees Say 3Health News:Cardin Calls on NIH to Utilize Small Businesses for Extramural Research Projects 2Health News:Courage Camps Maintain Summer Camp Schedule for Children and Adults With Disabilities 2
The Shandon Cryotome SME Cryostat model is a sophisticated, top of the line cryostat that combines automated electronic advance and hands-free sectioning with fully independent specimen temperature c...
The Shandon Linistain SLS Linear Stainer is an economical mid-size linear stainer for staining procedures that do not require heat....
... E+ is a precision rotary ... advance with manual cutting. The ... easy to operate. Coarse Advance ... option of manually advancing the ...
The new Shandon HistocentreTM 3 is an integral part of the workflow in Histology laboratories, representing a workstation that complements any automatic tissue processor....
Medicine Products: